Caroline Palomeque Stock Analyst Profile - Maxim Group Research Coverage - Stocknear

Caroline Palomeque

Stock Analyst at Maxim Group

(3.74)
# 2225
Out of 5,508 analysts
13
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

10 Stocks

Name Action PT Current % Upside Ratings Updated
DARE Dare Bioscience
Upgrades: Buy
8
2.21 261.99% 3 Sep 4, 2025
HRMY Harmony Biosciences
Initiates Coverage On: Buy
59
26.87 119.58% 1 Sep 7, 2023
KRYS Krystal Biotech
Initiates Coverage On: Buy
154
184.87 -16.7% 1 Sep 7, 2023
HALO Halozyme Therapeutic...
Reinstates: Buy
58
67.73 -14.37% 1 Mar 27, 2023
CERE Cerevel Therapeutics...
Reinstates: Hold
22
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
166
211.28 -21.43% 1 Aug 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
39
15.26 155.57% 1 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
61
10.62 474.39% 1 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
9.67 313.65% 1 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Apr 8, 2022